Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving ...

NASA's ultra-sterile cleanrooms aren't as microbe-free as once thought. Scientists have discovered 26 new bacterial species ...

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

Bharat Biotech’s oral cholera vaccine, Hillchol, aims to ease a critical global shortfall, with the world currently lacking ...

Hyderabad-based Bharat Biotech International Ltd. has claimed that its oral cholera vaccine (OCV) under development, Hillchol ...

Addressing the “International Centre for Genetic Engineering and Biotechnology” (ICGEB) Board Meeting of Governors here today ...

Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.

India is set to undertake its first-ever biological experiments aboard the International Space Station (ISS). Announcing this ...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Bharat Biotech's Hillchol oral cholera vaccine completes phase III trials, proving non-inferiority and potential for global distribution.